Cargando…
Blood–Brain Barrier Modulation to Improve Glioma Drug Delivery
The blood–brain barrier (BBB) is formed by brain microvascular endothelial cells that are sealed by tight junctions, making it a significant obstacle for most brain therapeutics. The poor BBB penetration of newly developed therapeutics has therefore played a major role in limiting their clinical suc...
Autores principales: | Luo, Huilong, Shusta, Eric V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697580/ https://www.ncbi.nlm.nih.gov/pubmed/33198244 http://dx.doi.org/10.3390/pharmaceutics12111085 |
Ejemplares similares
-
Modulation of the Blood–Brain Barrier for Drug Delivery to Brain
por: Han, Liang
Publicado: (2021) -
Drug delivery strategies to enhance the permeability of the blood–brain barrier for treatment of glioma
por: Zhang, Fang, et al.
Publicado: (2015) -
Modeling the blood–brain barrier using stem cell sources
por: Lippmann, Ethan S, et al.
Publicado: (2013) -
Past and Current Perspectives in Modeling Bacteria and Blood–Brain Barrier Interactions
por: Kim, Brandon J., et al.
Publicado: (2019) -
Nanoscale drug delivery systems and the blood–brain barrier
por: Alyautdin, Renad, et al.
Publicado: (2014)